LEXINGTON, Mass., March 28, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Company will report its fourth quarter 2024 financial and...
Hence then, the article about curis to report fourth quarter 2024 financial and operating results and host conference call and webcast on march 31 2025 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Curis to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on March 31, 2025 )
Also on site :
- ‘Michael’ Director Antoine Fuqua On A Convo He Had With Michael Jackson, Reshoots, The Sequel & Choices Made About Pop Icon’s Controversies
- After the gunshots, JD Vance was first to be pulled off stage, then Trump and the first lady. Someone started a ‘U.S.A.’ chant but was shushed
- Marshals Episode 9 Ends With Chilling Warning From Kayce's Nemesis: 'Like The Duttons, My Legacy Is Growing'